What We Do

Leverage extensive industry knowledge. Contribute insightful thinking. Deliver rapid diligence. Maximize investment value through unique strategies.

Whether you’re buying a company, trying to sell one, or seeking to optimize the value of your investment, you need answers to critical business questions—and you need them fast. What are the real growth prospects? Are the revenue forecasts accurate? What are the greatest risk factors? How can we maximize the value of this business going forward?

Because healthcare is our sole focus, Health Advances is able to quickly integrate knowledge from our clinical, technical, and business perspectives to provide strategic insights that help you make more confident investment decisions.

How We Help Your Business

Fact-based analysis and insights. Pragmatic, actionable recommendations.

Our teams have a deep working knowledge of the broad healthcare industry ecosystem and market trends. This enables us to:

Examples

Paula Ness Speers: “Our recent evaluation of the API sector helped a financial investor understand this highly fragmented intermediate market when published research and statistics were scarce. Leveraging senior level contacts at the target’s key pharma and biotech customers helped shape a solid understanding of the OEMs’ decision making processes for selecting API suppliers as well as helped compare the target to its competition. Health Advances’ deep knowledge of the market trends for specific drugs in development and those already on the market also enabled a robust forecast of the various end-products for which the API were used.”

Mark Speers: “In the compressed timelines of these projects, most clients are not only eager to gain our perspectives on a target’s existing business, but they also want our estimates for sales synergies and ideas for directions to grow the target though further acquisitions. So, we start developing strategies during commercial diligence projects. These insights help clients more confidently move forward with transactions as they can better see the roadmap to value creation.”

Featured Areas

Financial Investor Diligence
Strategic Investor Diligence
Strategy & Implementation for New Investments
Positioning Companies for Sale

View our investors case examples

Or visit our Biopharma, Medtech, Health IT, and Diagnostics and Life Sciences Tools pages for specific strategic expertise.

Practice Leaders

Contact the Health Advances Diligence and Investor Team

Recent News, Events & Publications

07.02.15

Juno Therapeutics and Celgene Ink 10 Year Deal

Read the latest blog post

The Celgene and Juno Therapeutics executive teams held a joint webcast on June 30th, 2015 to discuss their newly announced large-scale collaboration deal in T-cell technologies.

By Alison Munroe